Apr 3 |
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
|
Mar 27 |
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) is a favorite amongst institutional investors who own 50%
|
Mar 16 |
Longboard Pharmaceuticals: After Stellar Gains, A Period Of Relative Calm Seems Likely
|
Mar 14 |
Longboard Pharmaceuticals Inc Reports Full Year 2023 Financial Results
|
Mar 12 |
Recap: Longboard Pharmaceuticals Q4 Earnings
|
Mar 12 |
Longboard Pharmaceuticals files for mixed shelf offering
|
Mar 12 |
Longboard Pharmaceuticals GAAP EPS of -$2.39 beats by $0.02
|
Mar 12 |
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
|
Feb 16 |
Longboard stock up 8% as Citi initiates at buy, citing takeover potential
|
Feb 2 |
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
|